Chronic myeloproliferative disorder with ETV6-PDGFRβ fusion gene

Ann Hematol. 2012 Apr;91(4):637-8. doi: 10.1007/s00277-011-1296-y. Epub 2011 Jul 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • ETS Translocation Variant 6 Protein
  • Female
  • Humans
  • Imatinib Mesylate
  • Middle Aged
  • Myeloproliferative Disorders / drug therapy
  • Myeloproliferative Disorders / genetics*
  • Piperazines / therapeutic use
  • Proto-Oncogene Proteins c-ets / genetics*
  • Proto-Oncogene Proteins c-ets / metabolism
  • Pyrimidines / therapeutic use
  • Receptor, Platelet-Derived Growth Factor beta / genetics*
  • Receptor, Platelet-Derived Growth Factor beta / metabolism
  • Recombinant Fusion Proteins / genetics*
  • Recombinant Fusion Proteins / metabolism
  • Repressor Proteins / genetics*
  • Repressor Proteins / metabolism

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Proto-Oncogene Proteins c-ets
  • Pyrimidines
  • Recombinant Fusion Proteins
  • Repressor Proteins
  • Imatinib Mesylate
  • Receptor, Platelet-Derived Growth Factor beta